Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD).

Autor: Kavanagh PV; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, Ireland., Westphal F; State Bureau of Criminal Investigation Schleswig-Holstein, Section Narcotics/Toxicology, Kiel, Germany., Pulver B; State Bureau of Criminal Investigation Schleswig-Holstein, Section Narcotics/Toxicology, Kiel, Germany.; Institute of Forensic Medicine, Forensic Toxicology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Elliott SP; Elliott Forensic Consulting, Birmingham, UK.; Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK., Stratford A; Synex Synthetics BV, Maastricht, The Netherlands., Halberstadt AL; Department of Psychiatry, University of California San Diego, La Jolla, California, USA.; Research Service, VA San Diego Healthcare System, San Diego, California, USA., Brandt SD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.

Publikováno v: Drug testing and analysis [Drug Test Anal] 2024 Apr 03. Date of Electronic Publication: 2024 Apr 03.

Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).

Autor: Brandt SD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK., Kavanagh PV; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin 8, Ireland., Gare S; Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, UK., Elliott SP; Elliott Forensic Consulting, Birmingham, UK.; Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK., Stratford A; Synex Synthetics BV, Maastricht, The Netherlands., Halberstadt AL; Department of Psychiatry, University of California San Diego, La Jolla, USA.; Center for Psychedelic Research, University of California San Diego, La Jolla, USA.; Research Service, VA San Diego Healthcare System, San Diego, USA.

Publikováno v: Drug testing and analysis [Drug Test Anal] 2024 Dec 03. Date of Electronic Publication: 2024 Dec 03.

In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing.

Autor: Richter MJ; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany., Wagmann L; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany., Kavanagh PV; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin 8, Ireland., Brandt SD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK., Meyer MR; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Publikováno v: Drug testing and analysis [Drug Test Anal] 2023 Feb; Vol. 15 (2), pp. 181-191. Date of Electronic Publication: 2022 Oct 26.

(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.

Autor: Rudin D; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., McCorvy JD; Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA., Glatfelter GC; Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Luethi D; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Szöllősi D; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Ljubišić T; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Kavanagh PV; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, 8, Ireland., Dowling G; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, 8, Ireland.; Department of Life Sciences, School of Science, Sligo Institute of Technology, Ash Lane, Sligo, Ireland., Holy M; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Jaentsch K; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Walther D; Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Brandt SD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.; Alexander Shulgin Research Institute, Lafayette, CA, USA., Stockner T; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria., Baumann MH; Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Halberstadt AL; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.; Research Service, VA San Diego Healthcare System, La Jolla, CA, USA., Sitte HH; Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria. harald.sitte@meduniwien.ac.at.; Center for Addiction Research and Science-AddRess, Medical University Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria. harald.sitte@meduniwien.ac.at.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2022 Mar; Vol. 47 (4), pp. 914-923. Date of Electronic Publication: 2021 Nov 08.

Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233.

Autor: Brandt SD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK., Kavanagh PV; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, Ireland., Westphal F; Section Narcotics/Toxicology, State Bureau of Criminal Investigation Schleswig-Holstein, Kiel, Germany., Dreiseitel W; Hessian State Bureau of Criminal Investigation, Wiesbaden, Germany., Dowling G; Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James Hospital, Dublin, Ireland.; Department of Life Sciences, School of Science, Sligo Institute of Technology, Ash Lane, Sligo, Ireland., Bowden MJ; Stargate International, Auckland, New Zealand., Williamson JPB; Synex Synthetics BV, Maastricht, The Netherlands.

Publikováno v: Drug testing and analysis [Drug Test Anal] 2021 Jan; Vol. 13 (1), pp. 175-196. Date of Electronic Publication: 2020 Sep 22.